MedPath

Management of Tamaka shwasa

Phase 3
Conditions
Health Condition 1: J454- Moderate persistent asthma
Registration Number
CTRI/2024/08/071857
Lead Sponsor
Government Ayurveda Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects having classical symptoms of Tamaka Shwasa with atleast 3 symptoms and for a duration of atleast 3 months are selected for the study

Subjects who are willing to be a part of research work and are ready to sign the written consent will be selected

Mild to Moderate condition according to GINA parameters

Peak Expiratory Flow Rate within 60 to 90 percentage

Exclusion Criteria

Peak Expiratory Flow Rate less than 60 percentage

History of any Cardiac involvement Cyanosis

Uncontrolled Diabetes Mellitus and Hypertension

Pregnant and Lactating women

Any anatomical defect in airway and other complicated respiratory disorders like TB Emphysema Bronchiectasis Carcinoma etc

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of Subjective parameters will be done based on classical symptoms of Tamaka Shwasa <br/ ><br>Assessment of Objective parameters will be done based on Auscultation Peak Expiratory Flow Rate <br/ ><br>Timepoint: 15days
Secondary Outcome Measures
NameTimeMethod
Assessment of Severity will be done Before Treatment After Treatment & during the Follow upTimepoint: 22 days
© Copyright 2025. All Rights Reserved by MedPath